Jazz Pharmaceuticals Operating Expenses 2010-2024 | JAZZ
- Jazz Pharmaceuticals annual operating expenses for 2023 were $3.256B, a 12.6% decline from 2022.
- Jazz Pharmaceuticals annual operating expenses for 2022 were $3.725B, a 27.39% increase from 2021.
- Jazz Pharmaceuticals annual operating expenses for 2021 were $2.924B, a 47.27% increase from 2020.